Company news
Skrr Exploration, Inc. (TSXV:SKRR) news
Skrr Exploration, Inc. news releases on 6ix. Latest, Aug 28, 2020: SKRR Exploration Inc. Announces Appointment of Mr. Brian Skanderbeg as a Special Advisor…
Press releases — page 3
SKRR Exploration Inc. Announces Appointment of Mr. Brian Skanderbeg as a Special Advisor to the Board of Directors
August 28, 2020
SKRR Exploration Inc. Closes C$1.175 Million Private Placement
August 25, 2020
SKRR Exploration Inc. Announces Private Placement Financing
August 21, 2020
SKRR Exploration Inc. Announces Listing on Frankfurt Stock Exchange
August 20, 2020
Phase One Field Work Completed on the Olson Gold Project, Northern Saskatchewan
July 27, 2020
SKRR Increases Olson Gold Project Land Package in Northern Saskatchewan
June 23, 2020
SKRR Announces Work Program for Leland Gold Project, Saskatchewan
June 8, 2020
SKRR Exploration Inc. Announces Private Placement
June 2, 2020
SKRR Commences Exploration on Olson Gold Project, Northern Saskatchewan
June 2, 2020
SKRR Exploration Inc. and Taiga Gold Execute Option Agreement for Leland Gold Project, Saskatchewan
May 21, 2020
SKRR Amends Option Agreement to Acquire the Irving Lake Property in Saskatchewan, Canada
May 14, 2020
SKRR Signs Option Agreement to Acquire the Irving Lake Property in Saskatchewan, Canada
April 27, 2020
SKRR Exploration Inc. Reports 2020 AGM Results
March 23, 2020
SKRR Exploration Inc. Announces Change of Venue for Annual General and Special Meeting to Be Held on March 23, 2020
March 17, 2020
SKRR Closes Ithingo Lake Property Option Agreement
March 13, 2020
SKRR Exploration Inc. - Early Warning Report Filed Pursuant to National Instrument 62-103
March 11, 2020
SKRR Signs Option Agreement to Acquire the Ithingo Lake Gold Project in Saskatchewan, Canada
March 4, 2020
SKRR Exploration Inc. Signs Definitive Agreement to Acquire the Cathro Gold Project, Saskatchewan
February 12, 2020
IIROC Trading Halt - CSC.H
January 21, 2019
IIROC Trade Resumption - Canex Energy Corp.
February 8, 2018
IIROC Trading Halt - CSC
June 8, 2017
IIROC Trade Halt - Canex Energy Corp.
June 8, 2017
IIROC Trading Resumption - CSC
July 4, 2016
Canex Drill Update and TSX Approval on Property Extension
November 5, 2015
Canex and Fission 3.0 Extend Clearwater West Property Option Agreement
October 21, 2015
Canex Encounters 2,333 cps Anomalous Radioactivity by Down-hole Gamma Probe in 3rd Drill Hole at Clearwater West
August 4, 2015
Canex Collars First Hole and Begins Drilling with JV Partner at Clearwater West
July 27, 2015
Canex and Fission 3.0 Mobilize Drill Rig for Seven Hole Drill Program at Clearwater West
July 20, 2015
Canex Appoints New CFO
July 14, 2015
Canex Announces Closing Of Oversubscribed Second Tranche In Non-Brokered Private Placement
June 30, 2015
Canex appoints Ross McElroy as Technical Advisor and announces non-brokered private placement
May 14, 2015
Mick Shmazian Joins Brades Resource as Advisor, Sets Options
March 6, 2015
Brades Resource Corp And Fission 3.0 Target Large Anomaly Cluster On The Clearwater West Property
October 15, 2014
Ryan Kalt Announces Acquisition of Common Shares of Brades Resource Corp. - ("BRA")
August 15, 2013
IIROC Trading Resumption - BRA
November 1, 2012
IIROC Trade Resumption - Brades Resource Corp.
November 1, 2012
Oncothyreon to begin trading today on NASDAQ and TSX
December 11, 2007
Court issues final order approving Biomira's move to U.S. and name change to Oncothyreon
December 5, 2007
Biomira Shareholders Approve Move to U.S.
December 4, 2007
Biomira Inc. receives Nasdaq delisting notification
November 5, 2007
Biomira Inc. announces date for special meeting of shareholders; Oncothyreon Inc. registration statement declared effective
November 1, 2007
Biomira announces third quarter 2007 financial results
November 1, 2007
Biomira to present at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
October 30, 2007
New data may help guide the clinical development of Biomira's PX-478 and PX-866
October 24, 2007
Biomira to present at the BIO InvestorForum 2007
October 3, 2007
Biomira announces plan to change name to Oncothyreon
September 27, 2007
Biomira Announces Plan to Reincorporate in the United States
September 12, 2007
Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
September 5, 2007
Biomira initiates Phase 1 trial of PX-478 in patients with advanced metastatic cancers
August 28, 2007
Biomira and Merck KGaA sign amended and restated collaboration and supply agreements related to Stimuvax(R)
August 8, 2007